Related references
Note: Only part of the references are listed.Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study
Cheng-Ta Li et al.
NEUROIMAGE (2010)
Physical activity and memory functions: Are neurotrophins and cerebral gray matter volume the missing link?
A. Floeel et al.
NEUROIMAGE (2010)
Open-Label Support for Duloxetine for the Treatment of Panic Disorder
Naomi M. Simon et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
The role of ceramide in major depressive disorder
Johannes Kornhuber et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Brain Volume Abnormalities in Major Depressive Disorder: A Meta-Analysis of Magnetic Resonance Imaging Studies
P. Cedric M. P. Koolschijn et al.
HUMAN BRAIN MAPPING (2009)
Functional but not structural changes associated with learning: An exploration of longitudinal Voxel-Based Morphometry (VBM)
Adam G. Thomas et al.
NEUROIMAGE (2009)
Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project
Nader Perroud et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Sexually dimorphic gray matter volume reduction in patients with panic disorder
Takeshi Asami et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder
Kaan Yucel et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Neural correlates of attention biases of people with major depressive disorder: a voxel-based morphometric study
K. -K. Leung et al.
PSYCHOLOGICAL MEDICINE (2009)
Depression-related variation in brain morphology over 3 years -: Effects of stress?
Thomas S. Frodl et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake
Claudio Mannari et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression:: A voxel-based morphometry study
Nenad Vasic et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder
David G. S. Perahia et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies
J. P. Hamilton et al.
MOLECULAR PSYCHIATRY (2008)
Regional gray matter abnormalities in panic disorder:: A voxel-based morphometry study
Ricardo R. Uchida et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2008)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Duloxetine - A review of its use in the treatment of major depressive disorder
James E. Frampton et al.
CNS DRUGS (2007)
Duloxetine in the treatment of panic disorder
Jos Alexandre S. Crippa et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Increased brainstem volume in panic disorder: a voxel-based morphometric study
X Protopopescu et al.
NEUROREPORT (2006)
An update on regional brain volume differences associated with mood disorders
S Campbell et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study
HK Yoo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression
H Lavretsky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Cerebral glucose metabolism associated with a fear network in panic disorder
Y Sakai et al.
NEUROREPORT (2005)
Deep brain stimulation for treatment-resistant depression
HS Mayberg et al.
NEURON (2005)
Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling
PC Guest et al.
BRAIN RESEARCH (2004)
Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment
M Vythilingam et al.
BIOLOGICAL PSYCHIATRY (2004)
Hippocampal volume and depression: A meta-analysis of MRI studies
P Videbech et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat
M Kodamo et al.
BIOLOGICAL PSYCHIATRY (2004)
Role of neurotrophic factors in the etiology and treatment of mood disorders
RS Duman
NEUROMOLECULAR MEDICINE (2004)
Neurobiology of emotion perception II: Implications for major psychiatric disorders
ML Phillips et al.
BIOLOGICAL PSYCHIATRY (2003)
Glia as a putative target for antidepressant treatments
H Manev et al.
JOURNAL OF AFFECTIVE DISORDERS (2003)
Parahippocampal gray matter density in panic disorder:: A voxel-based morphometric study
G Massana et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
The functional neuroanatomy of the placebo effect
HS Mayberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Brain metabolic changes associated with symptom factor improvement in major depressive disorder
AL Brody et al.
BIOLOGICAL PSYCHIATRY (2001)
Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling
PJ Magistretti
BRAIN RESEARCH (2000)
Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response
HS Mayberg et al.
BIOLOGICAL PSYCHIATRY (2000)
Lifetime panic-depression comorbidity in the National Comorbidity Survey - Association with symptoms, impairment, course and help-seeking
PP Roy-Byrne et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Suicide attempts in the Hungarian adult population. Their relation with DIS/DSM-III-R affective and anxiety disorders
E Szadoczky et al.
EUROPEAN PSYCHIATRY (2000)
Share Paper
